— Know what they know.
Not Investment Advice
Also trades as: BRKR (NASDAQ) · $vol 135M

BRKRP NASDAQ

Bruker Corporation
1W: +6.3% 1M: -5.0% 3M: -2.3% YTD: +22.3% 1Y: +41.0%
$446.32
+20.61 (+4.84%)
 
Weekly Expected Move ±4.9%
$383 $404 $424 $445 $466
NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 37 · $9.3B mcap · 104M float · 0.0061% daily turnover · Short 73% of daily vol
Credit Risk of going bust: higher than 59% of companies Debt: 17.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $10.76 (down 98%), Bruker Corporation would be worth roughly what it owes.
Total debt $1.92B against a stock market value of $9.25B.
Distance to default 4.30 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.01B (short-term plus half of long-term), stock volatility 57.2%; Altman Z 2.85. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$6.2B +7.5% ▲
5Y CAGR: +15.4%
Total Liabilities
$3.7B -6.5% ▼
5Y CAGR: +12.5%
Shareholders Equity
$2.5B +37.9% ▲
5Y CAGR: +20.6%
Cash & Investments
$299M +62.9% ▲
5Y CAGR: -16.4%
Total Debt
$2.0B -9.0% ▼
5Y CAGR: +17.5%
Net Debt
$1.7B -15.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$1.1B$646M$488M$183M$299M
Short-Term Investments$100M$0$0$0$0
Cash & ST Investments$1.2B$646M$488M$183M$299M
Net Receivables$417M$595M$622M$701M$736M
Inventory$710M$800M$968M$1.1B$1.1B
Other Current Assets$177M$29M$30M$40M$48M
Total Current Assets$2.5B$2.1B$2.2B$2.1B$2.2B
Property, Plant & Equip.$466M$538M$691M$815M$911M
Goodwill & Intangibles$551M$728M$913M$2.4B$2.4B
Long-Term Investments$0$0$0$0$8M
Other Non-Current Assets$71M$155M$184M$233M$241M
Total Non-Current Assets$1.2B$1.5B$2.1B$3.8B$4.0B
Total Assets$3.6B$3.6B$4.2B$5.8B$6.2B
— Liabilities —
Accounts Payable$147M$178M$203M$234M$216M
Short-Term Debt$112M$19M$121M$32M$52M
Deferred Revenue$336M$370M$400M$438M$441M
Other Current Liabilities$156M$160M$218M$300M$303M
Total Current Liabilities$938M$914M$1.2B$1.3B$1.3B
Long-Term Debt$1.2B$1.2B$1.2B$2.1B$1.7B
Other Non-Current Liab.$267M$166M$240M$311M$239M
Total Non-Current Liabilities$1.6B$1.6B$1.6B$2.7B$2.5B
Total Liabilities$2.6B$2.5B$2.8B$4.0B$3.7B
— Equity —
Common Stock$2M$2M$2M$2M$2M
Retained Earnings$1.7B$1.9B$2.3B$2.4B$2.4B
Accumulated OCI-$8M$15M$6M-$104M-$80M
Total Stockholders Equity$1.1B$1.1B$1.4B$1.8B$2.5B
Total Liabilities & Equity$3.6B$3.6B$4.2B$5.8B$6.2B
— Key Metrics —
Total Debt$1.4B$1.3B$1.4B$2.2B$2.0B
Net Debt$326M$625M$891M$2.1B$1.7B
Total Investments$100M$0$0$0$8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms